Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

69.16
Delayed Data
As of Apr 24
 +1.18 / +1.74%
Today’s Change
48.98
Today|||52-Week Range
72.58
+16.84%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month+0.70% 3 years+17.75%
3 months+10.95% 5 years+21.91%
1 year+19.80% Since inception+14.02%
Data through 04/25/2017

Quote Details

Previous close$67.98
Open day’s range68.39 – 69.36
Net asset value (NAV)69.23 (04/24/2017)
Daily volume2,942,695
Average volume (3 months)4,789,018
Data as of 04/24/2017

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+21.91%+16.30%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.781.05
Net assets$3.1B$3.0B
Average market cap$5.0B$29.5B
Average P/E--24.1
Dividend / Share--0.28%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
VRTX Vertex Pharmaceuticals Inc2.85%
BIVV Bioverativ Inc2.52%
BLUE bluebird bio Inc2.52%
CLVS Clovis Oncology Inc2.50%
CELG Celgene2.46%
EXEL Exelixis Inc2.46%
REGN Regeneron Pharmaceuticals2.45%
GILD Gilead Sciences2.44%
ABBV AbbVie2.43%
IONS Ionis Pharmaceuticals Inc2.36%